U.S.-based global health non-profit organisation, PATH, is testing a single-use contraceptive injection in Africa. The jab uses the Uniject injection system developed in the 1980s to make injections simpler in the developing world. Bob Mezan reports.
U.S.-based global health non-profit organisation, PATH, is testing a single-use contraceptive injection in Africa. The jab uses the Uniject injection system developed in the 1980s to make injections simpler in the developing world. Robert Mezan reports. STORY: For millions of women across the world, access to birth control can be challenge. But a new, single use injectable contraceptive promises an easy, safe, and discreet method of family planning. Called Sayana Press, it's a three-month, progestin injection that can be administered by health care providers, or even women themselves. Sayana Press is a combination of the Pfizer product, Sayana, and a uniject syringe system, developed by medical supply manufacturer Becton Dickinson. It was the original idea of PATH, an international health organization based in Seattle, Washington. The injection is currently being tested in places like the remote regions of Uganda, where only 30 percent of married woman use some sort of contraception, according to a report by the Guttmacher Institute. SOUNDBITE: Sara Tifft, PATH Reproductive Health Program Officer, saying (English): "We met a young woman in rural Uganda who wanted to use contraception but she had to hide it from her husband, and she was having trouble getting away from her farm and her home to go to the clinic. The community health worker in her village learned how to use Sayana Press and administer it to her. So she would meet this woman in the field while she was planting her crops, give her an injection, and away she'd go. Her family never needed to know because she never needed to leave home or break her work routine." The treatment is also very affordable. In a pricing agreement arranged between Pfizer, the Bill & Melinda Gates Foundation, and the Children's Investment Fund Foundation, the Sayana Press can be purchased in the world's 69 poorest countries for one dollar a dose.